|
1
|
Lefebvre V and Bhattaram P: Vertebrate
skeletogenesis. Curr Top Dev Biol. 90:291–317. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao Q, Eberspaecher H, Lefebvre V and De
Crombrugghe B: Parallel expression of Sox9 and Col2a1 in cells
undergoing chondrogenesis. Dev Dyn. 209:377–386. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yoshida CA, Kawane T, Moriishi T,
Purushothaman A, Miyazaki T, Komori H, Mori M, Qin X, Hashimoto A,
Sugahara K, et al: Overexpression of Galnt3 in chondrocytes
resulted in dwarfism due to the increase of mucin-type O-glycans
and reduction of glycosaminoglycans. J Biol Chem. 289:26584–26596.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Holmbeck K, Bianco P, Caterina J, Yamada
S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I,
et al: MT1-MMP-deficient mice develop dwarfism, osteopenia,
arthritis, and connective tissue disease due to inadequate collagen
turnover. Cell. 99:81–92. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Watanabe H, Nakata K, Kimata K, Nakanishi
I and Yamada Y: Dwarfism and age-associated spinal degeneration of
heterozygote cmd mice defective in aggrecan. Proc Natl Acad Sci
USA. 94:6943–6947. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bernfield M, Götte M, Park PW, Reizes O,
Fitzgerald ML, Lincecum J and Zako M: Functions of cell surface
heparan sulfate proteoglycans. Annu Rev Biochem. 68:729–777. 1999.
View Article : Google Scholar
|
|
7
|
Esko JD and Lindahl U: Molecular diversity
of heparan sulfate. J Clin Invest. 108:169–173. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ai X, Do AT, Kusche-Gullberg M, Lindahl U,
Lu K and Emerson CP Jr: Substrate specificity and domain functions
of extracellular heparan sulfate 6-O-endosulfatases, QSulf1 and
QSulf2. J Biol Chem. 281:4969–4976. 2006. View Article : Google Scholar
|
|
9
|
Pye DA, Vives RR, Turnbull JE, Hyde P and
Gallagher JT: Heparan sulfate oligosaccharides require
6-O-sulfation for promotion of basic fibroblast growth factor
mitogenic activity. J Biol Chem. 273:22936–22942. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sedita J, Izvolsky K and Cardoso WV:
Differential expression of heparan sulfate 6-O-sulfotransferase
isoforms in the mouse embryo suggests distinctive roles during
organogenesis. Dev Dyn. 231:782–794. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song K, Li Q, Peng YB, Li J, Ding K, Chen
LJ, Shao CH, Zhang LJ and Li P: Silencing of hHS6ST2 inhibits
progression of pancreatic cancer through inhibition of Notch
signalling. Biochem J. 436:271–282. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ashikari-Hada S, Habuchi H, Kariya Y, Itoh
N, Reddi AH and Kimata K: Characterization of growth factor-binding
structures in heparin/heparan sulfate using an octasaccharide
library. J Biol Chem. 279:12346–12354. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Robinson CJ, Harmer NJ, Goodger SJ,
Blundell TL and Gallagher JT: Cooperative dimerization of
fibroblast growth factor 1 (FGF1) upon a single heparin saccharide
may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary
complexes. J Biol Chem. 280:42274–42282. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Savage MP and Fallon JF: FGF-2 mRNA and
its antisense message are expressed in a developmentally specific
manner in the chick limb bud and mesonephros. Dev Dyn. 202:343–353.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Niswander L and Martin GR: Fgf-4
expression during gastrulation, myogenesis, limb and tooth
development in the mouse. Development. 114:755–768. 1992.PubMed/NCBI
|
|
16
|
Crossley PH and Martin GR: The mouse Fgf8
gene encodes a family of polypeptides and is expressed in regions
that direct outgrowth and patterning in the developing embryo.
Development. 121:439–451. 1995.PubMed/NCBI
|
|
17
|
Gonzalez AM, Buscaglia M, Ong M and Baird
A: Distribution of basic fibroblast growth factor in the 18-day rat
fetus: localization in the basement membranes of diverse tissues. J
Cell Biol. 110:753–765. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jingushi S, Scully SP, Joyce ME, Sugioka Y
and Bolander ME: Transforming growth factor-beta 1 and fibroblast
growth factors in rat growth plate. J Orthop Res. 13:761–768. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Larbuisson A, Dalcq J, Martial JA and
Muller M: Fgf receptors Fgfr1a and Fgfr2 control the function of
pharyngeal endoderm in late cranial cartilage development.
Differentiation. 86:192–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Murakami S, Kan M, McKeehan WL and de
Crombrugghe B: Up-regulation of the chondrogenic Sox9 gene by
fibroblast growth factors is mediated by the mitogen-activated
protein kinase pathway. Proc Natl Acad Sci USA. 97:1113–1118. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Akiyama H, Chaboissier MC, Martin JF,
Schedl A and de Crombrugghe B: The transcription factor Sox9 has
essential roles in successive steps of the chondrocyte
differentiation pathway and is required for expression of Sox5 and
Sox6. Genes Dev. 16:2813–2828. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bi W, Deng JM, Zhang Z, Behringer RR and
de Crombrugghe B: Sox9 is required for cartilage formation. Nat
Genet. 22:85–89. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang W, Zhong B, Sun J, Cao J, Tian J,
Zhong N, Zhao W, Tian L, Xu P, Guo D, et al: Down-regulated HS6ST2
in osteoarthritis and Kashin-Beck disease inhibits cell viability
and influences expression of the genes relevant to aggrecan
metabolism of human chondrocytes. Rheumatology (Oxford).
50:2176–2186. 2011. View Article : Google Scholar
|
|
24
|
Backen AC, Cole CL, Lau SC, Clamp AR,
McVey R, Gallagher JT and Jayson GC: Heparan sulphate synthetic and
editing enzymes in ovarian cancer. Br J Cancer. 96:1544–1548. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pollari S, Käkönen RS, Mohammad KS,
Rissanen JP, Halleen JM, Wärri A, Nissinen L, Pihlavisto M,
Marjamäki A, Perälä M, et al: Heparin-like polysaccharides reduce
osteolytic bone destruction and tumor growth in a mouse model of
breast cancer bone metastasis. Mol Cancer Res. 10:597–604. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hatabe S, Kimura H, Arao T, Kato H,
Hayashi H, Nagai T, Matsumoto K, DE Velasco M, Fujita Y, Yamanouchi
G, et al: Overexpression of heparan sulfate 6-O-sulfotransferase-2
in colorectal cancer. Mol Clin Oncol. 1:845–850. 2013.
|
|
27
|
Di Maro G, Orlandella FM, Bencivenga TC,
Salerno P, Ugolini C, Basolo F, Maestro R and Salvatore G:
Identification of targets of Twist1 transcription factor in thyroid
cancer cells. J Clin Endocrinol Metab. 99:E1617–E1626. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gasimli L, Hickey AM, Yang B, Li G, dela
Rosa M, Nairn AV, Kulik MJ, Dordick JS, Moremen KW, Dalton S and
Linhardt RJ: Changes in glycosaminoglycan structure on
differentiation of human embryonic stem cells towards mesoderm and
endoderm lineages. Biochim Biophys Acta. 1840:1993–2003. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu J, Auduong L, White ES and Yue X:
Up-regulation of heparan sulfate 6-O-sulfation in idiopathic
pulmonary fibrosis. Am J Respir Cell Mol Biol. 50:106–114.
2014.
|
|
30
|
Waaijer CJ, de Andrea CE, Hamilton A, van
Oosterwijk JG, Stringer SE and Bovée JV: Cartilage tumour
progression is characterized by an increased expression of heparan
sulphate 6O-sulphation-modifying enzymes. Virchows Arch.
461:475–481. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kato Y and Gospodarowicz D: Sulfated
proteoglycan synthesis by confluent cultures of rabbit costal
chondrocytes grown in the presence of fibroblast growth factor. J
Cell Biol. 100:477–485. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ornitz DM: FGFs, heparan sulfate and
FGFRs: complex interactions essential for development. BioEssays.
22:108–112. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ferreras C, Rushton G, Cole CL, Babur M,
Telfer BA, van Kuppevelt TH, Gardiner JM, Williams KJ, Jayson GC
and Avizienyte E: Endothelial heparan sulfate 6-O-sulfation levels
regulate angiogenic responses of endothelial cells to fibroblast
growth factor 2 and vascular endothelial growth factor. J Biol
Chem. 287:36132–36146. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nagai N, Habuchi H, Sugaya N, Nakamura M,
Imamura T, Watanabe H and Kimata K: Involvement of heparan sulfate
6-O-sulfation in the regulation of energy metabolism and the
alteration of thyroid hormone levels in male mice. Glycobiology.
23:980–992. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qu X, Carbe C, Tao C, Powers A, Lawrence
R, van Kuppevelt TH, Cardoso WV, Grobe K, Esko JD and Zhang X:
Lacrimal gland development and Fgf10-Fgfr2b signaling are
controlled by 2-O- and 6-O-sulfated heparan sulfate. J Biol Chem.
286:14435–14444. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lefebvre V and de Crombrugghe B: Toward
understanding SOX9 function in chondrocyte differentiation. Matrix
Biol. 16:529–540. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Akiyama H, Lyons JP, Mori-Akiyama Y, Yang
X, Zhang R, Zhang Z, Deng JM, Taketo MM, Nakamura T, Behringer RR,
et al: Interactions between Sox9 and beta-catenin control
chondrocyte differentiation. Genes Dev. 18:1072–1087. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Asai N, Ohkawara B, Ito M, Masuda A,
Ishiguro N and Ohno K: LRP4 induces extracellular matrix
productions and facilitates chondrocyte differentiation. Biochem
Biophys Res Commun. 451:302–307. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lamanna WC, Kalus I, Padva M, Baldwin RJ,
Merry CL and Dierks T: The heparanome - the enigma of encoding and
decoding heparan sulfate sulfation. J Biotechnol. 129:290–307.
2007. View Article : Google Scholar : PubMed/NCBI
|
